Werewolf Therapeutics (HOWL) Payables (2020 - 2026)
Werewolf Therapeutics (HOWL) posted quarterly Payables of $1.9 million for Q2 2026, down 62.52% year-over-year from $5.2 million in Q2 2025, and down 94.02% on a QoQ basis from $32.4 million in Q1 2026.
Werewolf Therapeutics (HOWL) Payables (2020 - 2026) Analysis & Trends
Werewolf Therapeutics has reported Payables for 7 years, with the latest figure at $1.9 million in Q2 2026.
- Payables for Q2 2026 came in at $1.9 million, down 62.52% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.9 million (down 62.52% YoY), and the FY2025 annual result was $29.0 million, up 855.19% from the prior year.
- Payables slipped to $1.9 million in Q2 2026, from $32.4 million in the prior quarter.
- Over five years, Payables peaked at $32.4 million in Q1 2026 and troughed at $986000.0 in Q1 2025.
- A 5-year average of $6.5 million and a median of $2.3 million in 2022 frame the typical range for Payables.
- The widest annual swing landed in 2025, when Payables plunged 92.56%; it then surged 3186.0% in 2026.
- A 5-year view of Payables shows it stood at $1.2 million in 2022, then soared by 555.45% to $8.0 million in 2023, then sank by 62.08% to $3.0 million in 2024, then surged by 855.19% to $29.0 million in 2025, then tumbled by 93.31% to $1.9 million in 2026.
- Per Business Quant data, the three most recent Payables figures were $1.9 million in Q2 2026, $32.4 million in Q1 2026, and $29.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.05 Bn | 131.20 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 78.00 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.49 Bn | 60.31 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.79 Bn | 51.65 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.05 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.71 Bn | 9.32 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | 35.57 Mn |
| 10 | Werewolf Therapeutics | 43.91 Mn | 43.91 Mn | - | 1.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Mn |
| Mar 31, 2026 | 32.40 Mn |
| Dec 31, 2025 | 28.99 Mn |
| Sep 30, 2025 | 7.08 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 986,000.00 |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 13.26 Mn |
| Dec 31, 2023 | 8.00 Mn |
| Sep 30, 2023 | 3.05 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 1.22 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 2.59 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 2.04 Mn |
| Sep 30, 2021 | 1.46 Mn |